Synonym
COH34; COH-34; COH 34
IUPAC/Chemical Name
(E)-1-(((p-Tolylthio)imino)methyl)naphthalen-2-ol
InChi Key
SFUAIBHPGDRCFL-XDHOZWIPSA-N
InChi Code
InChI=1S/C18H15NOS/c1-13-6-9-15(10-7-13)21-19-12-17-16-5-3-2-4-14(16)8-11-18(17)20/h2-12,20H,1H3/b19-12+
SMILES Code
OC1=CC=C2C=CC=CC2=C1/C=N/SC3=CC=C(C)C=C3
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
293.38
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Martincuks A, Zhang C, Austria T, Li YJ, Huang R, Lugo Santiago N, Kohut A,
Zhao Q, Borrero RM, Shen B, Cristea M, Wang EW, Song M, Rodriguez-Rodriguez L,
Yu H. Targeting PARG induces tumor cell growth inhibition and antitumor immune
response by reducing phosphorylated STAT3 in ovarian cancer. J Immunother
Cancer. 2024 Apr 5;12(4):e007716. doi: 10.1136/jitc-2023-007716. PMID: 38580335;
PMCID: PMC11002370.
2: Chen SH, Yu X. Targeting dePARylation selectively suppresses DNA repair-
defective and PARP inhibitor-resistant malignancies. Sci Adv. 2019 Apr
10;5(4):eaav4340. doi: 10.1126/sciadv.aav4340. PMID: 30989114; PMCID:
PMC6457938.
3: Li P, Zhu X, Qu H, Han Z, Yao X, Wei Y, Li B, Chen H. Synergistic Effect of
Ubiquitin-Specific Protease 14 and Poly(ADP-Ribose) Glycohydrolase Co-Inhibition
in BRCA1-Mutant, Poly(ADP-Ribose) Polymerase Inhibitor-Resistant Triple-Negative
Breast Cancer Cells. Onco Targets Ther. 2024 Sep 6;17:741-753. doi:
10.2147/OTT.S463217. PMID: 39258222; PMCID: PMC11385694.
4: Tsuda K, Kurasaka C, Ogino Y, Sato A. Genomic and biological aspects of
resistance to selective poly(ADP-ribose) glycohydrolase inhibitor PDD00017273 in
human colorectal cancer cells. Cancer Rep (Hoboken). 2023 Feb;6(2):e1709. doi:
10.1002/cnr2.1709. Epub 2022 Aug 26. PMID: 36053937; PMCID: PMC9939995.
